Education
About Us
Working with TipRanks
Follow Us
Barinthus Biotherapeutics (BRNS)
NASDAQ:BRNS
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 14.97M | $ 802.00K | $ 44.70M | $ 268.00K | $ 4.82M |
| Gross Profit | $ 14.97M | $ 802.00K | $ 44.70M | $ 268.00K | $ -9.57M |
| Operating Income | $ -67.97M | $ -83.91M | $ -4.04M | $ -45.22M | $ -20.05M |
| EBITDA | $ -55.37M | $ -71.06M | $ 5.19M | $ -47.87M | $ -16.56M |
| Net Income | $ -61.07M | $ -73.35M | $ 5.34M | $ -50.87M | $ -17.71M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 110.66M | $ 142.09M | $ 194.38M | $ 214.05M | $ 43.27M |
| Total Assets | $ 160.33M | $ 214.51M | $ 270.20M | $ 280.71M | $ 50.67M |
| Total Debt | $ 12.01M | $ 12.98M | $ 8.77M | $ 7.22M | $ 46.36M |
| Net Debt | $ -98.66M | $ -129.11M | $ -185.61M | $ -206.83M | $ 3.10M |
| Total Liabilities | $ 30.19M | $ 27.51M | $ 27.00M | $ 28.15M | $ 53.81M |
| Stockholders' Equity | $ 130.03M | $ 186.78M | $ 242.90M | $ 252.13M | $ -3.54M |
| Cash Flow | |||||
| Free Cash Flow | $ -29.83M | $ -56.34M | $ -20.57M | $ -33.73M | $ -11.32M |
| Operating Cash Flow | $ -28.94M | $ -50.92M | $ -14.43M | $ -32.58M | $ -11.03M |
| Investing Cash Flow | $ -892.00K | $ -5.41M | $ -5.75M | $ -12.91M | $ -293.00K |
| Financing Cash Flow | $ 2.16M | $ 1.87M | $ 325.00K | $ 222.74M | $ 41.44M |